Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Milestone Pharmaceuticals Inc. (MIST) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $7.45 Metrics
OS: 33.4 M
Market cap: $249 M
Net cash: $39.5 M $1.18 per share
EV: $209 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues15.0-5.9-8.9-3.98.3
            Revenue growth-352.7%-33.2%126.8%-147.4% 
Cost of goods sold7.00.00.00.08.3
Gross profit8.0-5.9-8.9-3.90.0
            Gross margin53.3%100.0%100.0%100.0%0.0%
Research and development38.734.542.016.8 
General and administrative12.410.37.03.11.5
EBIT-43.1-50.7-57.9-23.8-8.3
            EBIT margin-287.2%854.1%650.9%607.5%-100.0%
Pre-tax income-42.9-50.0-55.3-23.10.0
Income taxes0.00.0-0.10.10.0
            Tax rate0.0%0.0%0.1%  
Net income-42.9-50.0-55.2-23.20.0
            Net margin-285.7%841.6%621.1%591.3%0.0%
 
Diluted EPS($1.02)($1.70)($3.50)($72.63) 
Shares outstanding (diluted)42.029.415.80.3 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy